CellaVision AB Share Price OTC Markets
Stocks
CLVSF
SE0000683484
Advanced Medical Equipment & Technology
OTC Markets Traded|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.49 USD | -16.39% |
|
-.--% | -19.83% |
| 17/06 | Stockholm Stock Exchange trades near flat at the open, OMXS30 unchanged | FW |
| 17/06 | Aktiespararna sees upside in CellaVision after share price collapse: issues buy rating | FW |
| Market Cap | 326.29Cr 34Cr 30Cr 27Cr 26Cr 48Cr 3.22TCr 49Cr 126.72Cr 1.59TCr 128.16Cr 125.42Cr 5.5TCr | P/E 2026 * |
22.5x | P/E 2027 * | 18.7x |
|---|---|---|---|---|---|
| Enterprise Value | 304.47Cr 32Cr 28Cr 26Cr 24Cr 45Cr 3TCr 45Cr 118.24Cr 1.48TCr 119.59Cr 117.03Cr 5.13TCr | EV / Sales 2026 * |
3.95x | EV / Sales 2027 * | 3.48x |
| Free-Float |
83.08% | Yield 2026 * |
2.01% | Yield 2027 * | 2.25% |
Last Transcript: CellaVision AB
| 1 day | -16.39% | ||
| 3 months | -16.39% | ||
| 6 months | -19.83% | ||
| Current year | -19.83% |
| Current year | 13.49 |  | 17.3 |
| 1 year | 13.49 | | 17.3 |
| 3 years | 13.49 | | 25.9 |
| 5 years | 13.49 | | 34.75 |
| 10 years | 13.49 | | 41.48 |
| Manager | Title | Age | Since |
|---|---|---|---|
Steve Ferguson
CEO | Chief Executive Officer | - | 05/06/2026 |
Monica Jonsson
DFI | Director of Finance/CFO | 46 | 02/09/2025 |
Helena Raihle
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 61 | - | |
Stefan Wolf
BRD | Director/Board Member | 62 | 04/05/2018 |
Mikael Worning
CHM | Chairman | 64 | 29/04/2021 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -16.39% | -.--% | - | - | 34Cr | |
| -0.97% | -7.70% | -0.84% | -29.48% | 1.55TCr | |
| -2.00% | -5.85% | +25.78% | +48.91% | 157.18Cr | |
| +1.58% | +2.61% | -25.69% | +24.51% | 111.54Cr | |
| +4.11% | -2.98% | -51.75% | -84.40% | 93Cr | |
| +5.56% | +6.44% | -16.36% | -51.84% | 68Cr | |
| +0.58% | -1.38% | -40.36% | -58.31% | 55Cr | |
| +3.24% | -4.53% | +37.29% | -54.10% | 44Cr | |
| -0.24% | -1.88% | -53.89% | -62.94% | 38Cr | |
| +3.15% | +7.66% | +11.04% | +4.36% | 33Cr | |
| Average | -0.14% | -1.19% | -12.75% | -29.25% | 238.77Cr | |
| Weighted average by Cap. | -0.51% | -4.60% | -3.87% | -25.35% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 77Cr 8.07Cr 7.04Cr 6.49Cr 6.1Cr 11Cr 761.01Cr 11Cr 30Cr 375.04Cr 30Cr 30Cr 1.3TCr | 86Cr 9.03Cr 7.86Cr 7.25Cr 6.82Cr 13Cr 850.58Cr 13Cr 33Cr 419.17Cr 34Cr 33Cr 1.45TCr |
| Net income | 14Cr 1.52Cr 1.32Cr 1.22Cr 1.15Cr 2.14Cr 142.94Cr 2.16Cr 5.63Cr 70Cr 5.69Cr 5.57Cr 244.15Cr | 17Cr 1.82Cr 1.59Cr 1.46Cr 1.38Cr 2.58Cr 171.73Cr 2.59Cr 6.76Cr 85Cr 6.84Cr 6.69Cr 293.34Cr |
| Net Debt | -22Cr -2.28Cr -1.99Cr -1.83Cr -1.73Cr -3.23Cr -215.22Cr -3.25Cr -8.47Cr -106.06Cr -8.57Cr -8.39Cr -367.61Cr | -27Cr -2.78Cr -2.42Cr -2.24Cr -2.1Cr -3.93Cr -262.27Cr -3.96Cr -10Cr -129.25Cr -10Cr -10Cr -447.99Cr |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CEVI Stock
- CLVSF Stock
Select your edition
All financial news and data tailored to specific country editions
